BioWorld-Insight-2002-05-27
Many Investors Discouraged By Data From ASCO Meeting
Many Investors Discouraged By Data From ASCO Meeting
Although the American Society of Clinical Oncology meeting in Orlando, Fla., which wrapped up last week, spewed much data and generated plenty of talk, the news wasn't all good for biotechnology firms, nor was it all bad. In a down market, however, the word "mixed" doesn't carry quite the cautious optimism it once did at least not for those with cash on the line. (BioWorld Financial Watch)
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: March 26 - May 22, 2002#
No Abstract
Biotech - Biotech Collaborations: Modified And Terminated Agreements, March 26 - May 22, 2002#
No Abstract

